BioLineRx Net Worth

BioLineRx Net Worth Analysis

Know BioLineRx's Top Institutional Investors

Note, although BioLineRx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow BioLineRx's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.63 M.

Project BioLineRx's profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (9.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $9.38.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate BioLineRx's management efficiency

BioLineRx has return on total asset (ROA) of (0.2198) % which means that it has lost $0.2198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2003) %, meaning that it created substantial loss on money invested by shareholders. BioLineRx's management efficiency ratios could be used to measure how well BioLineRx manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.34 in 2025. Return On Capital Employed is likely to drop to -0.91 in 2025. At this time, BioLineRx's Total Assets are fairly stable compared to the past year. Intangible Assets is likely to rise to about 10.5 M in 2025, whereas Other Assets are likely to drop 0.86 in 2025. BioLineRx time-series forecasting models is one of many BioLineRx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioLineRx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

BioLineRx Earnings per Share Projection vs Actual

BioLineRx Corporate Management

Additional Tools for BioLineRx Stock Analysis